Chronic obstructive pulmonary disease

J Int Med Res. 2001 Mar-Apr;29(2):49-50. doi: 10.1177/147323000102900201.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / therapeutic use
  • Aza Compounds*
  • Cost of Illness
  • Female
  • Fluoroquinolones*
  • Humans
  • Lung Diseases, Obstructive / drug therapy
  • Lung Diseases, Obstructive / economics
  • Lung Diseases, Obstructive / etiology
  • Lung Diseases, Obstructive / physiopathology*
  • Male
  • Moxifloxacin
  • Quinolines*
  • Smoking / adverse effects

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin